Standardized Endoscopic Swallowing Evaluation for Tracheostomy Decannulation in Critically Ill Neurologic Patients - a prospective evaluation.

Aspiration Decannulation Dysphagia FEES Intensive care Tracheostomy

Journal

Neurological research and practice
ISSN: 2524-3489
Titre abrégé: Neurol Res Pract
Pays: England
ID NLM: 101767802

Informations de publication

Date de publication:
10 May 2021
Historique:
received: 13 03 2021
accepted: 22 04 2021
entrez: 10 5 2021
pubmed: 11 5 2021
medline: 11 5 2021
Statut: epublish

Résumé

Removal of a tracheostomy tube in critically ill neurologic patients is a critical issue during intensive care treatment, particularly due to severe dysphagia and insufficient airway protection. The "Standardized Endoscopic Evaluation for Tracheostomy Decannulation in Critically Ill Neurologic Patients" (SESETD) is an objective measure of readiness for decannulation. This protocol includes the stepwise evaluation of secretion management, spontaneous swallowing, and laryngeal sensitivity during fiberoptic endoscopic evaluation of swallowing (FEES). Here, we first evaluated safety and secondly effectiveness of the protocol and sought to identify predictors of decannulation success and decannulation failure. A prospective observational study was conducted in the neurological intensive care unit at Münster University Hospital, Germany between January 2013 and December 2017. Three hundred and seventy-seven tracheostomized patients with an acute neurologic disease completely weaned from mechanical ventilation were included, all of whom were examined by FEES within 72 h from end of mechanical ventilation. Using regression analysis, predictors of successful decannulation, as well as decannulation failure were investigated. Two hundred and twenty-seven patients (60.2%) could be decannulated during their stay according to the protocol, 59 of whom within 24 h from the initial FEES after completed weaning. 3.5% of patients had to be recannulated due to severe dysphagia or related complications. Prolonged mechanical ventilation showed to be a significant predictor of decannulation failure. Lower age was identified to be a significant predictor of early decannulation after end of weaning. Transforming the binary SESETD into a 4-point scale helped predicting decannulation success in patients not immediately ready for decannulation after the end of respiratory weaning (optimal cutoff ≥1; sensitivity: 64%, specifity: 66%). The SESETD showed to be a safe and efficient tool to evaluate readiness for decannulation in our patient collective of critically ill neurologic patients.

Sections du résumé

BACKGROUND BACKGROUND
Removal of a tracheostomy tube in critically ill neurologic patients is a critical issue during intensive care treatment, particularly due to severe dysphagia and insufficient airway protection. The "Standardized Endoscopic Evaluation for Tracheostomy Decannulation in Critically Ill Neurologic Patients" (SESETD) is an objective measure of readiness for decannulation. This protocol includes the stepwise evaluation of secretion management, spontaneous swallowing, and laryngeal sensitivity during fiberoptic endoscopic evaluation of swallowing (FEES). Here, we first evaluated safety and secondly effectiveness of the protocol and sought to identify predictors of decannulation success and decannulation failure.
METHODS METHODS
A prospective observational study was conducted in the neurological intensive care unit at Münster University Hospital, Germany between January 2013 and December 2017. Three hundred and seventy-seven tracheostomized patients with an acute neurologic disease completely weaned from mechanical ventilation were included, all of whom were examined by FEES within 72 h from end of mechanical ventilation. Using regression analysis, predictors of successful decannulation, as well as decannulation failure were investigated.
RESULTS RESULTS
Two hundred and twenty-seven patients (60.2%) could be decannulated during their stay according to the protocol, 59 of whom within 24 h from the initial FEES after completed weaning. 3.5% of patients had to be recannulated due to severe dysphagia or related complications. Prolonged mechanical ventilation showed to be a significant predictor of decannulation failure. Lower age was identified to be a significant predictor of early decannulation after end of weaning. Transforming the binary SESETD into a 4-point scale helped predicting decannulation success in patients not immediately ready for decannulation after the end of respiratory weaning (optimal cutoff ≥1; sensitivity: 64%, specifity: 66%).
CONCLUSIONS CONCLUSIONS
The SESETD showed to be a safe and efficient tool to evaluate readiness for decannulation in our patient collective of critically ill neurologic patients.

Identifiants

pubmed: 33966636
doi: 10.1186/s42466-021-00124-1
pii: 10.1186/s42466-021-00124-1
pmc: PMC8108459
doi:

Types de publication

Journal Article

Langues

eng

Pagination

26

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : SU 922/1-1, WO1425/6-1, DZ 78/1-1

Références

Int J Stroke. 2017 Jun;12(4):430-437
pubmed: 27807279
Chest. 2007 Sep;132(3):1049-56
pubmed: 17873200
J Bronchology Interv Pulmonol. 2015 Oct;22(4):357-64
pubmed: 26348694
Cerebrovasc Dis. 2017;44(1-2):1-9
pubmed: 28395275
Curr Treat Options Neurol. 2014 Jan;16(1):274
pubmed: 24357462
Am J Respir Crit Care Med. 2002 Nov 15;166(10):1338-44
pubmed: 12421743
Dysphagia. 2014 Apr;29(2):256-61
pubmed: 24442645
Anaesth Crit Care Pain Med. 2018 Jun;37(3):281-294
pubmed: 29559211
Neurol Res Pract. 2020 Mar 30;2:9
pubmed: 33324915
Laryngoscope. 2015 Feb;125(2):365-70
pubmed: 25180960
Arch Phys Med Rehabil. 2005 Aug;86(8):1516-20
pubmed: 16084801
Muscle Nerve. 2019 Feb;59(2):194-200
pubmed: 30390307
J Am Med Dir Assoc. 2019 Apr;20(4):470-475.e1
pubmed: 30455047
Chest. 1996 Dec;110(6):1566-71
pubmed: 8989078
Neurocrit Care. 2019 Jun;30(3):546-554
pubmed: 30919303
Respir Med. 2010 May;104(5):749-53
pubmed: 20122822
Cerebrovasc Dis. 2004;18(4):325-31
pubmed: 15359100
Lancet Neurol. 2018 Oct;17(10):849-859
pubmed: 30170898
Crit Care Med. 2013 Oct;41(10):2396-405
pubmed: 23939361
Otolaryngol Head Neck Surg. 2005 Sep;133(3):366-71
pubmed: 16143183
Crit Care. 2018 Aug 17;22(1):195
pubmed: 30115127
Intensive Care Med. 2020 Apr;46(4):637-653
pubmed: 32076765
Respiration. 2012;84(6):469-76
pubmed: 22354154
Intensive Care Med. 2015 Sep;41(9):1629-37
pubmed: 26077087
Crit Care. 2008;12(1):R26
pubmed: 18302759
Aust Crit Care. 2009 Feb;22(1):8-15
pubmed: 19062302
Ann Otol Rhinol Laryngol. 2003 Oct;112(10):853-8
pubmed: 14587975
Respir Care. 2009 Dec;54(12):1644-52
pubmed: 19961629
Am J Crit Care. 2010 May;19(3):278-84
pubmed: 19435950
Laryngoscope. 2014 Aug;124(8):1794-800
pubmed: 24473939
Neurocrit Care. 2017 Aug;27(1):26-34
pubmed: 28324263
Intensive Care Med. 2003 May;29(5):845-8
pubmed: 12634987
Crit Care Med. 2017 Dec;45(12):2061-2069
pubmed: 29023260
Clin Interv Aging. 2016 Feb 23;11:189-208
pubmed: 26966356
Crit Care Med. 2013 Jul;41(7):1728-32
pubmed: 23774336
Crit Care Med. 2011 Jun;39(6):1482-92
pubmed: 21378554
Stroke. 2013 Jan;44(1):21-8
pubmed: 23204058
Cerebrovasc Dis Extra. 2017;7(3):130-139
pubmed: 28972945
Respir Care. 2005 Apr;50(4):511-5
pubmed: 15807913
Semin Neurol. 1996 Dec;16(4):329-40
pubmed: 9112312
Respir Care. 2005 Apr;50(4):542-9
pubmed: 15807919
J Am Med Dir Assoc. 2017 Jul 1;18(7):635.e1-635.e7
pubmed: 28363443
Crit Care Med. 2007 Jan;35(1):132-8
pubmed: 17133180
Crit Care. 2019 Mar 28;23(1):103
pubmed: 30922363
Chest. 1986 Sep;90(3):430-6
pubmed: 3527584
J Intensive Care. 2017 Jun 20;5:38
pubmed: 28649385
Laryngoscope. 2016 Sep;126(9):2057-62
pubmed: 26607056
Respir Care. 2010 Aug;55(8):1056-68
pubmed: 20667153

Auteurs

Paul Muhle (P)

University Hospital Muenster, Department of Neurology with Institute for Translational Neurology, Albert-Schweitzer-Campus 1 A, 48149, Muenster, Germany. muhlep@uni-muenster.de.
Institute for Biomagnetism and Biosignalanalysis, University Hospital Muenster, Malmedyweg 15, 48149, Muenster, Germany. muhlep@uni-muenster.de.

Sonja Suntrup-Krueger (S)

University Hospital Muenster, Department of Neurology with Institute for Translational Neurology, Albert-Schweitzer-Campus 1 A, 48149, Muenster, Germany.
Institute for Biomagnetism and Biosignalanalysis, University Hospital Muenster, Malmedyweg 15, 48149, Muenster, Germany.

Karoline Burkardt (K)

Raphaelsklinik Muenster, Department of General Surgery, Loerstraße 23, 48143, Muenster, Germany.

Sriramya Lapa (S)

University Hospital Frankfurt, Department of Neurology, Theodor-Stern-Kai 7, 60590, Frankfurt/Main, Germany.

Mao Ogawa (M)

Department of Rehabilitation Medicine I, School of Medicine, Fujita Health University, Toyoake, Aichi, Japan.

Inga Claus (I)

University Hospital Muenster, Department of Neurology with Institute for Translational Neurology, Albert-Schweitzer-Campus 1 A, 48149, Muenster, Germany.

Bendix Labeit (B)

University Hospital Muenster, Department of Neurology with Institute for Translational Neurology, Albert-Schweitzer-Campus 1 A, 48149, Muenster, Germany.
Institute for Biomagnetism and Biosignalanalysis, University Hospital Muenster, Malmedyweg 15, 48149, Muenster, Germany.

Sigrid Ahring (S)

University Hospital Muenster, Department of Neurology with Institute for Translational Neurology, Albert-Schweitzer-Campus 1 A, 48149, Muenster, Germany.

Stephan Oelenberg (S)

University Hospital Muenster, Department of Neurology with Institute for Translational Neurology, Albert-Schweitzer-Campus 1 A, 48149, Muenster, Germany.

Tobias Warnecke (T)

University Hospital Muenster, Department of Neurology with Institute for Translational Neurology, Albert-Schweitzer-Campus 1 A, 48149, Muenster, Germany.

Rainer Dziewas (R)

Klinikum Osnabrück, Department of Neurology, Am Finkenhügel 1, 49076, Osnabrück, Germany.

Classifications MeSH